• StraightUp Resources’ mission is to maximize shareholder wealth and value through mineral discoveries at projects with carefully analyzed potential, focused on the acquisition, development, and exploration of mineral resource properties in North America
• The company completed an IPO in March 2020 and has since acquired six properties in Canada and the United States (RLX NORTH, RLX SOUTH, BELANGER, FERDINAND, BEAR HEAD, WEST CAT MINE).
• Its Canadian properties are located in an area with a rich mining history and currently revealing a resurgence of gold-bearing deposits that were overlooked in the past
• Together with the recent acquisition of property in Nevada, StraightUp is positioning itself among companies of significant potential within this sector

StraightUp Resources (CSE: ST) is on a mission to maximize shareholder value and wealth through mineral discoveries at projects with robust potential, maintaining long-lasting partnerships, and continued focus on the acquisition, development, and exploration of mineral resource properties in North America. Since completing an initial public offering (“IPO”) in March last year and a non-brokered private placement a month later, the Sechelt, British Columbia-headquartered company embarked on a journey that has seen it acquire mining assets and conduct magnetic surveys and field examinations. The first in the series of acquisitions was the June 11, 2020 announcement that it had been granted the exclusive right and option to acquire certain unpatented mining claims comprising RLX North, RLX South, and Belanger Red Lake gold properties (https://ibn.fm/07JU2). Upon receiving exploration permits for the properties shortly thereafter, the company repatriated, re-logged, and assayed – compiled and reinterpreted – all available historical data for the Belanger property and subsequently announced results in February this year (https://ibn.fm/FbV4Y). In addition, a 43-101 Technical Report was also completed on the Belanger Property in June of this year. For its RLX North and RLX South assets (“RLX properties”), StraightUp Resources acquired a digital database of compilation and field exploration data for the properties in November 2020. The company then commenced the ground magnetic (“MAG”) survey in March this year and the Heli-borne MAG survey a few months later in July. With the latter MAG survey already complete, the company expects a final report early this month. “These projects are in the heart of the Red Lake Mining District, an area that is seeing a resurgence of gold-bearing deposits that were overlooked in the past,” commented StraightUp President and CEO Mark Brezer, following the completion of the Heli-borne MAG survey (https://ibn.fm/B2O97). “RLX North and South almost completely surround Great Bear Resources Sobel Project, and with our accumulated data from the region and upcoming MAG results, we can better pinpoint future drill programs.” This year also witnessed the second addition to StraightUp’s growing asset portfolio, when, in March, it acquired the Ferdinand Gold Property in Ontario. The property, situated near Red Lake, consists of 17 claims comprising 354 cells and encompassing 6,600 hectares. According to the press release detailing the terms of the acquisition, the Ferdinand Gold Property is situated within the prolific Uchi Subprovince, one of the most metal endowed greenstone belts in the world by square kilometer (https://ibn.fm/QcTwm). StraightUp, which in June initiated and received preliminary results on a high-resolution Heli-borne MAG survey on the Ferdinand Gold Property, has since started ground exploration. In describing this crucial milestone, Brezer noted that the exploration marks entry into an area that has been largely unexplored. “The Ferdinand Gold Project is within a crucial scale deformation zone that has never seen a drill hole. Results from our recent Heli-borne MAG survey have identified high priority targets and important geological structures for crews to begin prospecting, sampling, and mapping,” Brezer continued (https://ibn.fm/9lpBa). In July, StraightUp acquired the Bear Head Gold Property comprising 31 mining claims totaling 1,944 hectares in the Meen-Dempster Greenstone Belt, which hosts the Golden Patricia former gold mine that produced 620,000 ounces of gold at an average grade of 15.2 g/t from 1988-1997. According to Brezer, this acquisition complements the Ferdinand Gold Property. Last month, the company acquired the historic West Cat Mine in Nevada, US, marking its expansion into new mining districts as it continues to position itself among top-quality assets and companies. Through its focus on strategic acquisitions and exploration work, StraightUp Resources is making an indelible mark on the mining scene all the while maximizing shareholder wealth and value. For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to ST are available in the company’s newsroom at https://ibn.fm/STR

• Palliative care focuses on providing end-of-life care for chronically ill patients
• Preliminary research suggests cannabis relieves pain, appetite loss, anxiety
• RYAH is the leader in volume-control technology for plant-based medicine
• RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data

With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, is positioned to address the urgent need for cannabis-based solutions in palliative care. Palliative care is an emerging healthcare field that focuses on providing solutions that alleviate the suffering of patients with a chronic diagnosis, including cardiovascular disease, cancer, chronic respiratory disease, AIDS, and diabetes. While end-of-life care is not a curative approach, treatments provided to patients focus on improving quality of life and relieving symptoms such as pain, depression, anxiety, and appetite loss. The World Health Organization (“WHO”) states that only 14 percent of approximately 40 million people that need end-of-life care each year receive it (https://ibn.fm/Nt4zU). A growing body of research demonstrates that cannabis and cannabinoids help ease symptoms associated with many chronic diseases (https://ibn.fm/tJFnF). While the research is still ongoing, cannabis continues to be a physician-recommended option to alleviate suffering by relieving symptoms such as pain, anxiety, and loss of appetite. Accordingly, evidence suggests that cannabis can replace opioids or be used as a suitable cotreatment to reduce opioid load (https://ibn.fm/AzgTk), with 67 percent of oncologists reporting that medical cannabis was a helpful treatment in conjunction with standard pain management approaches (https://ibn.fm/67QXG). RYAH’s ecosystem of IoT products, including its volume-control devices, medicine-carrying components, and mobile applications, can provide a reliable way for researchers and clinicians to develop well-controlled environments to study the use of cannabis for palliative care. Accordingly, the company’s Smart Dry-Herb Dose-Measuring Inhaler is currently being used in one of the most extensive medical studies ever undertaken. Other devices to follow include a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage. The development of RYAH’s Data Ecosystem is part of the company’s goal of generating AI-powered models that can provide precision treatments for various diseases, including chronic conditions requiring end-of-life care. Along with delivering volume-controlled devices, RYAH’s technology stack includes QR tracking applications to track product formulations and dosing parameters, as well as mobile applications that can manage volumetric data and provide patient feedback. RYAH is dedicated to helping doctors and patients unlock the power of data to provide better patient outcomes. With its robust intellectual property portfolio, AI-powered technology, and suite of portable, cost-effective products, the company is positioned to capitalize on growth opportunities in the IoT and data intelligence sectors while providing critical volume-control solutions for the plant-based medical industry. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• USA CBD Expo will host their upcoming October conference at Chicago’s McCormick Place between October 28-30, 2021.
• Forming part of the nation’s largest CBD event series, the USA CBD Expo will cater to CBD industry newcomers and seasoned industry professionals alike
• The conference will play feature a series of keynote presentations and discussions delivered by some of the industry’s leading thinkers and innovators
• In addition, the Expo will also be host to over 500 of the industry’s largest and most pioneering brands who will showcase their diverse product ranges under a single roof

USA CBD Expo is set to host their upcoming conference in conjunction with presenting sponsor, 3Chi, the nation’s largest CBN and Delta-8 distributor, at Chicago’s McCormick Place on October 28-30, 2021. The event will mark a new iteration of the nation’s largest CBD event series, which will provide conference attendees with the unique opportunity to hear from over 50 expert speakers, visit hundreds of vendors, and network alongside thousands of their peers. The USA CBD Expo has long established a well-earned reputation as the United States’ largest dedicated CBD conference series, bringing together the entire CBD and Hemp industry within a single, comprehensive, and all-inclusive event. Having originally started with an exclusive focus on the global vaping community, the USA CBD Expo has expanded over the past several years, culminating in a series of all-encompassing, premier trade shows which seeks to provide delegates with a fun, thrilling experience that promotes business networking within the industry. The upcoming Expo, which has been designed to cater to CBD industry newcomers and seasoned industry professionals alike, will seek to introduce attendees to a carefully curated group of CEO’s, corporate leaders, and sector thought leaders who will delve deeper into the intricacies surrounding the industry through a series of educational seminars, keynote addresses, and workshops. Industry personalities in attendance at the conference will include the likes of Samm Macias and Nick Smeriglio, Angela Ardolino of CBD Dog Health; Asa Waldstein from the Supplement Advisory Group; Angela Boyce of Primo Gardens; and Jason Gann, star of Wilfred and representing Wilfred CBD, among a variety of other featured speakers. Seminars will focus on a wide array of topics, including providing attendees with an overview of changes within the commercial side of the CBD and hemp industry, current and future CBD market trends, health benefits, ongoing legalization efforts as well as medicinal use cases. Additionally, some of the scheduled talks include CBD for sexual wellness, psychedelics education, the power of medicinal mushroom extracts, information about delta-8 and its legality, among other diverse topics. In addition to its standout list of industry personalities and expert speakers, the USA CBD Expo will also bring together upwards of 500 of the industry’s largest and most pioneering brands under a single roof. Participants can explore and discover some of the CBD and hemp sector’s newest and most innovative products, ranging from edibles and beverages to cosmetics and pet products. Additional information about the USA CBD Expo, as well as details for registration, can be found at the USA CBD Expo website at https://usacbdexpo.com/

Date: October 29, 2021 Online Virtual Event Bitcoin Events is proud to announce the third edition of Crypto Fest, scheduled for October 29, 2021. This one-day online event will feature controversial speakers and discussions with a focus on Non-Fungible Tokens (“NFTs”) and Decentralized Finance (“DeFi”). This year’s event targets fintech professionals, cryptocurrency mining entities, retail and institutional investors, and crypto and NFT enthusiasts. It guarantees a jam-packed day with exciting keynotes, presentations, workshops, product exhibitions, competitions, entertainment and contentious topics that are specifically geared towards offering attendees value and the requisite knowledge to navigate through the crypto world. Over 2,500 attendees are expected to show up for the event. Additionally, over 30 global innovators and thought leaders in the blockchain and cryptocurrency industry will take the stage to discuss different topics and even engage in debates amongst each other. There will also be a Q&A session where the event’s speakers will answer attendees’ questions. Crypto Fest 2021 promises a great networking opportunity with some of the industry’s most progressive professionals across different industries including, but not limited to mining, trading, insurance, finance, software infrastructure, regulation, legal, auditing and investment, among others. The audience will learn everything about the different tools, techniques, and platforms available for effective crypto investment and trading, especially with the ongoing proliferation of alternative currencies. Through this event, attendees will discover how cryptocurrencies can enable financial inclusion and greater participation in the financial ecosystem. They will also understand the consumer demands of the future and learn how to develop strategies for successful cryptocurrency and blockchain implementation. The audience will explore different collaborations and even create new strategic partnerships at the available exhibition booths. The audiences’ chance to win prizes and giveaways from the event’s sponsors and partners is even more exciting. There will also be an after-party right after the main event where attendees will enjoy some music and interact even further with their colleagues and partners in the industry. Crypto Fest 2019 and 2020 were both successful in attendance and pushing the conversation around alternative currencies and blockchain. Bitcoin Events has made a name for itself as Africa’s leading blockchain and cryptocurrency event organizer since its inception in 2014. As such, Crypto Fest 2021 pledges to build on all the previous events and to take things a notch higher, creating more engagement and offering a platform through which individuals in the crypto and blockchain space can interact, learn and grow. This event guarantees value to attendees. With a lineup of world-class global speakers and specially-curated topics, attendees are guaranteed to leave with knowledge, contacts and ideas that will take their businesses to the next level. This has always been the goal with Crypto Fest, and this 2021 event promises to be no different.

• For those who want to be part of the virtual event, please register here for free (https://ibn.fm/5W1ac)
• Should you wish to exhibit at the event, visit our page here (https://ibn.fm/73PCQ)
• If you would like to become a speaker at the event, please submit your application here (https://ibn.fm/IPDxb)
• To sponsor the event, please visit (https://ibn.fm/whI98)

• Date: Nov. 8-9, 2021
• Venue: Adrienne Arsht Center for the Performing Arts, Miami
• Agenda: Two days of expert panels covering a variety of topics surrounding the psychedelics industry’s medicinal, corporate and regulatory impact and beyond
• Tickets and Registration Info: Visit https://microdose.buzz/wonderland/miami/

As the health and wellness industry evolves, a veritable flood of innovators searching for the next frontier in holistic product market opportunities has turned recently to the potential of entheogenic (psychedelic) substances long taboo under the umbrella of war-on-drugs regulations. In September, news that the federal government’s National Institute on Drug Abuse (“NIDA”) is providing a funding grant for a study into how psilocybin could help people quit smoking cigarettes showed the potential strength of the psychedelics reform movement (https://ibn.fm/gRbUg). Conference event series organizer Microdose’s Wonderland: Miami gathering promises to be the largest psychedelic medicine business event ever when it opens its doors Nov. 8-9 in Miami’s Adrienne Arsht Center for the Performing Arts, one of the largest performing arts centers in the United States (https://ibn.fm/L73Vg). During two days of panels covering subjects that range from the current state of regulatory acceptance of psychedelics and their uses to next-generation research and development, dozens of innovators and experts in the industry will address leading concerns for anyone interested in the sector. Former world heavyweight champion boxer Mike Tyson and two-time NBA Champion basketball player Lamar Odom will provide athletic celebrity to the event, with Tyson addressing neurological health and wellness and Odom talking on ketamine’s future possibilities. Microdose sponsors monthly events designed to promote the psychedelics industry and awareness of its financial potential. The company’s newsletter provides a continuous feed of news and updates on the industry’s businesses and marketplaces, merchandise and educational opportunities. The Wonderland event organizers have partnered with internationally award-winning design teams to make the in-person event unforgettable, using projection mapping technology to create an animated, living stage. A first set of annual awards, a competition to pitch to venture capitalists and the opportunity to obtain a need-based scholarship to Wonderland provide extra depth to the experience. Microdose anticipates an audience spanning more than 140 countries to experience the insights offered by panelists bookended by the University of California, San Francisco and Baltimore, Maryland’s Johns Hopkins University School of Medicine, with a wide array of corporate and non-profit interests on display. A second round of early-bird tickets are still available, as well as standard, business entry and VIP pricing. A virtual access pass is also available for participants who prefer to attend via the event’s livestream or review sessions that they may have initially missed. For further information on the November conference and to obtain tickets for the event, visit https://microdose.buzz/wonderland/miami/.

• Multi-State Operator Red White & Bloom Brands is a cannabis retail opportunity builder expanding via acquisitions to create a synergistic portfolio throughout North America
• The company recently completed strategic refinancing that reorganizes its debt under an agreement that matures in January 2023
• The company continues aiming to improve its EBITDA margins under a harmonious High Times brand throughout its retail stores in Michigan, Florida, and Illinois, and it continues to build additional opportunities in California, Arizona, Oklahoma, and Massachusetts
• North America is set to become the dominant producer market for cannabis, and Red White & Bloom’s multi-state operator efforts are positioning it to become one of the top names in the U.S. legal cannabis and hemp sector

Retail cannabis brand builder Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multi-state operator intent on becoming one of the top names in the U.S. legal cannabis and hemp sector, announced Sept. 27 the successful completion of refinancing that will replace $18.62 million in debentures plus accrued interest with a new principal amount that will be payable on the maturity date of Jan. 21, 2023 (https://ibn.fm/dfzJY). Red White & Bloom is a Canadian-based company working to build on its successes in United States markets through strategic brand acquisitions and partnerships. The company has closed or is in the process of closing on assets in Michigan, Illinois, Florida, Oklahoma, Massachusetts, and California. In September, Red White & Bloom announced a key element of that growth process with news that it has improved a Florida production facility, building it out to good manufacturing practice (“GMP”) standards as it takes aim at the Sunshine State’s growing market for edible cannabis derivatives (https://ibn.fm/HglMG). Forbes has reported that Florida is the third-largest cannabis market in the country by annual sales and the largest market for medical marijuana (https://ibn.fm/tDV1C). Despite the ongoing COVID-19 pandemic, Florida continues to be a huge draw for tourism and is becoming friendlier to cannabis-tolerant legislation, creating the potential for huge benefits for companies well situated to take advantage of the trend. And in Michigan, a focal point for Red White & Bloom’s development, the company received adult recreational use prequalification status last month and hopes to end the year with a big retail presence in the state (https://ibn.fm/JZ2TS). Red White & Bloom acquired exclusive rights to High Times-branded THC products in Michigan, Florida and Illinois last year as well as exclusive High Times naming rights for its retail outlets in those states, providing Red White & Bloom with the ability to harmonize all its stores with instant brand equity and expand its EBITDA margins (https://ibn.fm/30cI3). The company has built its footprint coast-to-coast, also establishing a presence in California, Arizona, Oklahoma, and Massachusetts. North America is set to become the dominant producer of cannabis, and in Canada cannabis retail outlets, producers, manufacturers, distributors and warehouses were declared to have “essential services” status during the COVID-19 pandemic by Alberta’s leadership, allowing business to proceed unhindered there. Cannabinoid drugs such as Marinol, Syndros, Cesamet, and Epidolex gained approval by the Food and Drug Administration for medicinal use in the United States, and 10 states have legalized psychoactive forms of cannabis for recreational drug use (https://ibn.fm/gBcbP). For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• Hydrogen represents an energy-intensive production process, and is also a difficult element to contain, with high volatility requiring extreme amounts of pressure for storage
• FuelPositive’s carbon-free ammonia solves the problem of volatile hydrogen on its own, using ammonia as the carrier, allowing end-users to convert the green ammonia back to hydrogen and produce electricity using hydrogen fuel cells
• Carbon-free ammonia can also be used as a fuel on its own without being converted to pure hydrogen
• In a partnership with National Compressed Air, FuelPositive plans to finish prototype carbon-free ammonia production units by the end of 2021 and commence high-visibility pilot programs in 2022

The aviation industry accounts for up to 3% of man-made CO2 emissions and 12% of CO2 from transport. Aviation giant Boeing (NYSE: BA) has pledged to reduce net carbon emissions by 50% of its 2005 total by 2050. This announcement was a part of several aviation company pledges to move toward eventual net-zero carbon emissions by 2050. Last year, Airbus (Frankfurt: AIRG.F) announced the company’s intention to build a hydrogen-fueled plane by 2035 (https://ibn.fm/zUvdY). Hydrogen is the ultimate net-zero carbon emission goal, but it comes with its own set of challenges. Initial hydrogen production as a fuel source is energy-intensive, and the end product is highly volatile. Extreme levels of pressure are required to store hydrogen, and there is currently no viable distribution infrastructure. Solutions to the problems posed by hydrogen are years away from being available. Committed to clean energy solutions, Toronto-based FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) offers an answer to hydrogen production and distribution issues via its proprietary modular and scalable carbon-free ammonia (“NH3”) technology. Ammonia is the perfect carrier for hydrogen, and an end-user can convert green ammonia back to the hydrogen element to produce electricity in hydrogen fuel cells. In fact, not only does the production of FuelPositive’s carbon-free NH3 require much less energy than producing hydrogen on its own, but it stores 65% more hydrogen than highly compressed pure hydrogen. Carbon-free ammonia can also be used as a fuel source itself, without converting it back to hydrogen. The transportation industry (planes, trains, ships, trucks, etc.) can be converted to use carbon-free ammonia as a fuel source just as easily as they are converted from gasoline or diesel fuel to propane or natural gas. Using carbon-free ammonia for this purpose would also eliminate the need for highly polluting ammonia production facilities – as there are no CO2 emissions associated with the FuelPositive process. NH3 is already used as fertilizer in agriculture, but according to Clifford, farms can use FuelPositive’s technology to produce carbon-free ammonia for multiple purposes, including to power tractors and harvesters, to replace propane in crop-drying systems, and in general to reduce the sector’s reliance on existing fossil fuel and fertilizer supply chains, potentially shielding farmers from unexpected price hikes. Worldwide, farmers are plagued by various threats to the health of their crops and businesses, from pesticide-resistance to severe weather and overwhelming demand, and in the absence of innovation, they are forced to try and tackle these emerging threats with old, ineffective tools (https://ibn.fm/teqPr). FuelPositive’s carbon-free NH3 would offer the agriculture sector a much-needed innovative approach it is in dire need of, if it wants to remain functional and continue growing. Recently, FuelPositive’s CEO Ian Clifford appeared on the Stock2Me podcast to discuss how his company’s NH3 technology has the potential to change the overall energy landscape using an “environmentally sound and economically viable process.” Compared to the current NH3 synthesis technologies, which generate extremely high CO2 emissions, FuelPositive’s technology is entirely carbon-free, Clifford explained (https://ibn.fm/64SzC). The company is now in the process of commercializing its technology, with plans to roll out demonstration units and pilot projects in early 2022. In May 2021, FuelPositive announced a partnership with National Compressed Air (“NCA”) and is currently working to execute a detailed production plan to complete the prototype builds by the end of 2021. Upon completion of these prototype builds, FuelPositive will be able to confirm the potential that its carbon-free ammonia technology holds for numerous sectors. FuelPositive is targeting three primary segments – agriculture, transportation and energy storage, but will initially focus its demonstration programs on agriculture. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Flora Growth recently announced it had signed an LOI to provide a Panama-based international importer and distributor with cannabinoid-containing food and beverages
• The announcement followed on the heels of regulatory changes passed by Panama’s National Legislative Assembly, which legalized the use of medical cannabis and its therapeutic properties
• In July, Flora Growth signed an LOI with an international distributor to supply its dried flower and derivatives, an immediate result of the legalization of the export of dried cannabis flower by Colombia’s government

As a wave of cannabis-focused regulatory changes sweeps across Latin America and the world at large, Flora Growth (NASDAQ: FLGC), an internationally focused cannabis brand builder leveraging natural, cost-effective cultivation practices to supply cannabis flower and derivatives to its diverse business divisions, is proving quick to take advantage of these opportunities. Following the legalization by Colombia’s government for the export of dried cannabis flower in July this year, for example, Flora immediately reacted, demonstrating an unmatched strategic readiness to make moves right away. The company signed a letter of intent (“LOI”) with Kiricann, a South Africa-based international distributor with distribution agreements in the EU, to supply its dried flower and derivatives (https://ibn.fm/2WsBq). Additionally, the company signed a non-binding LOI with Evergreen Pharmacare, a licensed Australia-based importer and distributor of medical cannabis products, to supply its premium dried flower and derivatives. According to a recent Benzinga article, the Colombian law positioned the company for continued expansion into global markets. Flora Growth, which boasts robust infrastructure, access to skilled agricultural labor, and a strong distribution network, is ideally poised for exports of its cannabis products to do very well worldwide (https://ibn.fm/oGUIN). The company’s low production cost of only $0.06 per gram of cannabis, which is approximately 97% less than the reported costs of Canadian companies Aphria ($1.85 per gram), Sundial ($1.86 per gram), and Tilray (NASDAQ: TLRY) ($2.36 per gram) (https://ibn.fm/Dewwf), equally give it a substantial competitive edge. In a move that appears to capitalize on these favorable conditions as well as the regulatory changes passed by Panama’s National Legislative Assembly on August 30, Flora Growth announced September 16 that it had signed an LOI with Panama-based Robust Farms Inc., an international importer and distributor. Under the terms contained in the letter, Flora will provide Robust Farms with cannabinoid-containing food and beverages through its Kasa Wholefoods division, a Colombian manufacturer of food and beverages. The Panamanian changes, contained in Bill 153, legalized the use of medical cannabis and its therapeutic properties and further created a regulatory framework to monitor and control access. Following the changes, authorized patients will have the right to access medical cannabis products through licensed pharmacies that will be responsible for distribution. “It’s expected that Panama will become the first country in Central America to regulate the use of medical cannabis, however, the new regulations must be approved by President Laurentino Cortizo,” the article notes. Flora Growth President and CEO Luis Merchan lauded Panamanian legislators and advocacy groups for their efforts to push forward the initiative to control and regulate medical cannabis. “Ultimately,” he continued, “it will help provide options for patients who are looking to improve their quality of life by utilizing emerging cannabinoid therapeutic treatment. We look forward to working with local partners to provide our cannabis products to the citizens of Panama.” As Flora Growth continues its global expansion, it is focused on creating a balance between international collaborations and serving local communities. The company intends to prioritize the protection of the earth and its resources and, therefore, first considers the global impacts of its actions before acting on a local level. This approach helps Flora enact positive connections to the communities it inhabits and stand out, particularly in Colombia. Flora Growth operates one of the largest outdoor cultivation facilities in the world with the aim of marketing a higher-quality premium product at below-market prices. Flora Growth offers low-cost cannabis cultivation through its 10.8 million square feet (247 acres) of licensed cultivation land in Colombia, an expansive product and brand portfolio, as well as a strategic global distribution platform. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

Date: October 29, 2021 Online Virtual Event Entrepreneurs, traders, investors, developers, fintech professionals, and industry enthusiasts are invited to the 3rd Annual Crypto Fest, scheduled for October 29, 2021. The first Crypto Fest, held back in 2019 in Cape Town, South Africa, was a first in the industry. The second one was held virtually in 2020, paving the way for the third edition that promises to be bigger and better. Presented by Bitcoin Events, Crypto Fest 2021 will have over 2,500 attendees, mainly comprising of technical decision-makers, payment specialists, global policymakers, marketing specialists, industry innovators, forex, and cryptocurrency traders, among others. Over 30 global innovators and thought leaders in the cryptocurrency and blockchain industry will present at the event, offering their informed opinions on critical issues and topics within the space. Bitcoin Events is Africa’s leading blockchain and cryptocurrency event organizer, a position it has held since 2015. It is the first company to host world-class bitcoin and blockchain conferences in the African market, with a combined attendance of over 12,000 from over 165 countries worldwide. Bitcoin Events takes the learnings from previous events to this third edition of the Crypto Fest, its most ambitious one yet. Attendees can expect networking opportunities with some of the industry’s most progressive professionals in finance, trading, mining, insurance, auditing, legal, software infrastructure, and more. They can also explore exciting collaborations and create new strategic partnerships, ultimately discovering the latest blockchain and cryptocurrency solutions, products, platforms, and services at the available exhibition booths. Speakers at the event will be drawn from various backgrounds to debate and contest controversial topics, tackling them from a unique standpoint. Attendees will also stand a chance to win prizes and giveaways from the event’s sponsors and partners. Sponsors of the event include the Amber Group, FTX, Svalbard money and CCW. This event will also feature trading and investment workshops where expert crypto traders and investors will teach attendees about the different tools, techniques, and platforms available for effective trading and investment. There will also be a Q&A session where experts and panelists will answer attendees’ questions. The 2021 Crypto Fest promises to be engaging, informative, and ground-breaking. It will tackle everything from controversial topics to the intricacies of Non-Fungible Tokens (“NFTs”) and Decentralized Finance (“DeFi”). Attendees will better understand regulations surrounding these two topics and the expectations that bitcoin and alternative currencies are slowly gaining traction worldwide. The event promises value and an opportunity for attendees to thrive in their respective industries.

• To learn more about the event, please visit our page (https://ibn.fm/iRUha)
• If interested in attending this virtual event, visit (https://ibn.fm/RjAIb)
• Should you wish to become a speaker at the event, please register using this link (https://ibn.fm/zqSlw)
• To sponsor the event, please visit this page (https://ibn.fm/hf8w2)
• To exhibit at the event, please register here (https://ibn.fm/uaNt8)

• Pharmacy services developer Avricore Health recently completed the initial phase of rolling out its HealthTab(TM) platform
• HealthTab(TM) partners with other health technology platforms to collect data from blood or other molecular samples to test them for illnesses ranging from COVID and flu to heart disease and diabetes
• Avricore’s platform is designed to not only provide medical condition information to patients, but to share it seamlessly with medical providers and researchers
• The company’s initial rollout took place through pharmacies in Ontario, Canada, but Avricore intends to continue expanding throughout Canada, into the United States and eventually into Europe

Health diagnostics technology innovator Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has completed the initial rollout of its point of care platform for providing patients with lab-quality results regarding COVID and other illnesses, and the company was featured just recently in a Bell2Bell podcast discussing its history, its next goals and the plans it has for development farther down the road. “I’ve always really believed that we need a true health care system that values early detection and screening if we really want to make sure that we’re not only saving lives but saving health care dollars in the future,” Avricore CEO Hector Bremner told Bell2Bell’s Stuart Smith (https://ibn.fm/PxlqO). “We’re really passionate about leading this charge. … We’ve now got a company that is in great shape and fully funded. And we’re growing, and we’ve got really a lot of blue sky ahead of us.” Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from the tests not only with the patient, but also with medical professionals and researchers without compromising health privacy. “Really, the objective here is to create a global network of pharmacies reporting back real-time information on patient data and that can be used for study and research purposes, which is a very, very high demand out there in the sector,” Bremner said. For the patient’s part, once the simple sample is collected testing takes about 15 minutes to deliver the results. The initial rollout has been accomplished by partnering with the Shoppers Drug Mart pharmacy network in Ontario, Canada, but the company anticipates continuing to expand through Shoppers Drug Mart’s almost 1,800 pharmacies across Canada, adding other pharmacies, and then entering the United States and the United Kingdom as well. “The nice thing is all this technology that we use, everything that we’re doing down there (in the United States), is already approved so we are not at a sort of regulatory or approval risk at any level expanding internationally,” he said. “We’re also really excited about opportunities in the UK and EU, which, I think people just don’t understand how big a market that really is — it’s still bigger than China and it is a place where I think we can do business reliably. Between the U.S., UK and Canada, there’s about 110,000 pharmacies.” Bremner said Avricore Health is also generating interest among Latin American and Caribbean countries for applications of its network in travel-related infectious disease diagnostics. The company’s cloud-based technology provides a network for high-quality analysis not only for illnesses such as COVID and influenza, but heart disease and diabetes as well, facilitating data-based follow-ups with medical providers. The global point-of-care diagnostics market was measured at nearly $34.5 billion in revenue last year by Fortune Business Insights, and it is expected to continue growing at a compound annual growth rate (“CAGR”) of 9.4 percent through 2028 (https://ibn.fm/WFy4E). For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• Pharmacy services developer Avricore Health recently completed the initial phase of rolling out its HealthTab(TM) platform
• HealthTab(TM) partners with other health technology platforms to collect data from blood or other molecular samples to test them for illnesses ranging from COVID and flu to heart disease and diabetes
• Avricore’s platform is designed to not only provide medical condition information to patients, but to share it seamlessly with medical providers and researchers
• The company’s initial rollout took place through pharmacies in Ontario, Canada, but Avricore intends to continue expanding throughout Canada, into the United States and eventually into Europe

Health diagnostics technology innovator Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has completed the initial rollout of its point of care platform for providing patients with lab-quality results regarding COVID and other illnesses, and the company was featured just recently in a Bell2Bell podcast discussing its history, its next goals and the plans it has for development farther down the road. “I’ve always really believed that we need a true health care system that values early detection and screening if we really want to make sure that we’re not only saving lives but saving health care dollars in the future,” Avricore CEO Hector Bremner told Bell2Bell’s Stuart Smith (https://ibn.fm/PxlqO). “We’re really passionate about leading this charge. … We’ve now got a company that is in great shape and fully funded. And we’re growing, and we’ve got really a lot of blue sky ahead of us.” Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from the tests not only with the patient, but also with medical professionals and researchers without compromising health privacy. “Really, the objective here is to create a global network of pharmacies reporting back real-time information on patient data and that can be used for study and research purposes, which is a very, very high demand out there in the sector,” Bremner said. For the patient’s part, once the simple sample is collected testing takes about 15 minutes to deliver the results. The initial rollout has been accomplished by partnering with the Shoppers Drug Mart pharmacy network in Ontario, Canada, but the company anticipates continuing to expand through Shoppers Drug Mart’s almost 1,800 pharmacies across Canada, adding other pharmacies, and then entering the United States and the United Kingdom as well. “The nice thing is all this technology that we use, everything that we’re doing down there (in the United States), is already approved so we are not at a sort of regulatory or approval risk at any level expanding internationally,” he said. “We’re also really excited about opportunities in the UK and EU, which, I think people just don’t understand how big a market that really is — it’s still bigger than China and it is a place where I think we can do business reliably. Between the U.S., UK and Canada, there’s about 110,000 pharmacies.” Bremner said Avricore Health is also generating interest among Latin American and Caribbean countries for applications of its network in travel-related infectious disease diagnostics. The company’s cloud-based technology provides a network for high-quality analysis not only for illnesses such as COVID and influenza, but heart disease and diabetes as well, facilitating data-based follow-ups with medical providers. The global point-of-care diagnostics market was measured at nearly $34.5 billion in revenue last year by Fortune Business Insights, and it is expected to continue growing at a compound annual growth rate (“CAGR”) of 9.4 percent through 2028 (https://ibn.fm/WFy4E). For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF